GenoFocus Inc (187420) — Cash Flow Quality Index
GenoFocus Inc (187420) has a Cash Flow Quality Index of 0.03x as of December 2025. Operating cash flow of ₩288.09 Million is below net income of ₩9.06 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 187420 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
GenoFocus Inc Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for GenoFocus Inc across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check GenoFocus Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for GenoFocus Inc (2014–2025)
Year-by-year earnings quality comparison for GenoFocus Inc. For live market cap and the full company financial profile, see GenoFocus Inc (187420) total market value.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | ₩3.50 Billion | ₩22.59 Billion | ▼ -84.0% |
| 2017 | 0.97x | ₩1.36 Billion | ₩1.41 Billion | ▲ +202.5% |
| 2016 | 0.32x | ₩516.09 Million | ₩1.61 Billion | ▼ -86.4% |
| 2015 | 2.36x | ₩2.85 Billion | ₩1.21 Billion | ▲ +1894.5% |
| 2014 | -0.13x | ₩-286.45 Million | ₩2.18 Billion | — |